Sponsored Research
 
Research Foundation for Mental Hygiene, Inc.
New York State Psychiatric Institute Division

Steven M. Papp, M.B.A., Administrative Director for Research and Development
Frank L. Mucha, M.B.A., Deputy Administrative Director

 

Principal
Investigator Sponsor Award Title
A Abi-Dargham MH59144-02 273,380 Prefrontal D1 and 5HT1a Receptors in Schizophrenia
A Abi-Dargham AA12759-01 340,468 Imaging Ventrostriatal Dopamine Transmission in Alcoholism
N Alia-Klein Stanley Foundation 21,000 Violence and Psychotic Disorders: Association with Insight and Medication
L Amsel AFSP 17,732 Pharmacological Treatment for Suicidal Ideation in Adolescents (PTSIA)
H Andrews Columbia Univ 46,981 Subcontract w/Columbia University: Epidemiology of Dementia in an Urban Community
H Andrews AG16381-01A1 172,304 Multicenter Vitamin E Trial in Persons with Down Syndrome
C Bailey MH37134-17 278,277 Morphological Basis of Synaptic Plasticity
M Baron Columbia Univ 388,686 Subcontract w/CU: Molecular Genetics of Bipolar Disorder
G Barr DA06600-10 129,740 Development and Plasticity of Opiate Withdrawal
B Beebe MH56130-02 100,511 Mother-Infant Regulation: Depression and Attachment
H Bird MH56401-04 1,679,822 Antisocial Behaviors in U.S. and Island Puerto Rican Youth
Z Boulos NS30528-06 128,098 Role of Twilights in Circadian Entrainment
Z Boulos Bio-Brite 59,204 Consortium w/Bio-Brite, Inc.: Light Visor for Treating Jet Lag: Controlled
A Brown NARSAD 50,000 Prenatal Viral and Nutritional Risk Factors for Schizophrenia: A Serologic
G Bruder MH36295-17 235,291 Behavioral, ERP and EEG Asymmetry in Affective Disorders
G Bruder MH50715-07 245,807 Brain ERPs and Cognitive Demand in Schizophrenia
C Caton DA10539-05 871,144 Service Needs in Early Psychosis and Drug Use
W Clark DE12725-02 286,964 Gender Differences in Pain Sensation and Pain Report
P Cohen MH54161-05 587,519 Accounting for Change in Psychopathology: Age 17 to 25
P Cohen MH60911-01A1 525,279 Personality Disorder Over 20 Years: Risks, Course & Impact
S Comer DE12763-03 367,462 Pain and Analgesic Response: Sex and Hormone Variations
S Comer DA10909-03 353,207 Buprenorphine Abuse by Humans: Laboratory Studies
L Covey DA13490-01 518,347 Maintenance Treatment for Prevention of Smoking Relapse
D Devanand Pfizer 5,480 Donepezil Augmentation of Sertraline in Depression with Cognitive Impairme
D Devanand MH55735-05 246,860 Clomipramine and Behavior Therapy in OCD
D Devanand Univ of NC 8,625 Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
P Devanand Pfizer 0 Gift Account from Pfizer
M Devlin MH54612-04 306,145 Psychotherapy and Medication for Binge Eating Disorder
S Donovan DA12234-02 357,394 Temper, Mood Swings & Marijuana -- A Treatable Syndrome?
A Dwork MH60877-06 340,882 AD-Like Pathology in Elderly Schizophrenia
L E-Kimling MH19560-29 619,027 Prospective Study of Children of Schizophrenic Parents
A Ehrhardt MH43520-13 2,419,254 HIV Center for Clinical and Behavioral Studies
A Ehrhardt MH57636-03 982,711 Health Related Interventions for Persons Living with HIV
J Endicott Pfizer 0 SADS-C (Modified for Bipolar Disorders)
J Endicott MH23864-28 150,587 NIMH Collaborative Depression Study
S Evans AA12599-02 305,808 Medications Development for Alcohol Abuse: NMDA Agents
S Evans DA09114-07 421,538 Vulnerbility to Anxiolytic Abuse in Women
T Exner HD37343-02 657,394 Increasing Dual Protection Among Low Income Minority Women
B Fallon MH55842-04 420,284 IV CMI in the Treatment of Refractory OCD
B Fallon Columbia Univ. 124,132 Subcontract w/CU: PET and MRI Imaging of Persistent Lyme Encephalopathy
B Fallon Solvay Pharm. 21,615 Fluvoxamine in Hypochondriasis
V Ferrera MH59244-03 183,484 Attention and Voluntary Action in Prefrontal Cortex
W Fifer HD32774-06 406,684 Perinatal Assessment of At-Risk Populations
W Fifer MH58769-03 25,000 Meeting of the International Society for Developmental Psychobiology
M Fischman Harvard Univ. 187,978 Subcontract w/Harvard Univ.: Drug Abuse, Sleep and Cognition
M Fischman DA03476-16 614,988 Drug Effects on Behavior: Workplace Implications
M Fischman DA12761-02 1,044,202 Novel Pharmacotherapies for Cocaine Dependence
M Fischman Brookhaven 35,485 Subcontract w/Brookhaven: Pharmacokinetics of Psychostimulants and Reinforcement
R Foltin DA04130-14 175,750 Anorectic Drugs: Abuse & Behavioral Mechanisms of Action
R Foltin DA08105-07 387,749 Laboratory Analysis of Cocaine Abstinence
R Foltin DA12675-01A1 266,415 Cocaine's Effects Across the Menstrual Cycle
R Foltin DA08464-06 200,353 Novel Animal Model for Treating Cocaine Craving
D Friedman AG05213-14 293,886 Age Effects on the Cognitive ERPD/Cardiac Wave Effect
D Friedman AG09988-08A1 298,912 Age-Related ERP Measures in Alzheimer's Disease
D Friedman HD14959-15 245,546 The Maturation of Cognitive-Related Brain Potentials
C Ghez North Shore Univ 43,998 Consortium w/North Shore Univ.: PET and Hyperkinetic Disorders: A Multicen
J Gibbon MH41649-15 138,432 Theory of Animal Timing: Memory and Choice
R Gil Bristol-Myers 17,075 A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Three
A Glassman Pfizer 290,208 A 7-Wk Double-blind, Placebo-controlled, Randomized, Multicenter Study Evaluation
J Gorman MH58808-02 260,697 The Role of Transthyretin in Depression
J Gorman NARSAD 99,946 An Analysis of Cytokine Levels in Maternal Serum as Markers of Prenatal Ex
J Gorman MH61274-01 487,361 CoGent for Mood and Anxiety Disorder Research
J Gorman MH59342-02 738,634 MHCRC in Schizophrenia Studies
J Gorman Cornell Univ 141,133 Consortium W/Cornell: Center for Neural Systems of Fear and Anxiety
J Gorman MH60951-02 423,661 Prospective Study of Relapse Predictors in Panic Disorder
M Gould CCU216089-03 200,000 An Evaluation of Telephone Crisis Services for Adolescents
L Greenhill MH47113-08 267,902 Biological Studies in Suicidal Adolescent Inpatients
L Greenhill Eli Lilly 4,874 Randomized, Double-Blind, Placebo-Controlled, Variable Discontinuation Study in Children with Attention-Deficit/Hyperactivity Disorder
L Greenhill Alza Corporation 10,020 Long-Term Safety and Effectiveness of OROS (methylphenidate HCI) in Children with ADHD (Part 1 and Part II)
L Greenhill Shire Labs 24,548 A Randomized, Double-Blind, Placebo and Active-Controlled Study of SLI381
L Greenhill Cephalon 92,099 Modafinil Analog Classroom ADHD Study
L Greenhill MH60903-01A1 675,719 Methylphenidate Efficacy and Safety in ADHD Preschoolers
L Greenhill Somerset Pharm. 33,906 Open-Label Extension Study of the STS in Pediatric Patients with ADHD
L Greenhill Noven Pharmaceuti 87,672 A Multicenter Double-Blind Placebo-Controlled Safety & Efficacy Study of M
L Greenhill MH12007 164,482 Follow-up of the Multimodal Treatment Study of Children with Attention Deficit
M Haney DA12698-01A1 416,688 THC and Marijuana: Effects in Individuals with HIV/AIDS
J Harkavy Frie MH56422-04 241,874 Suicidal Behavior in Schizophrenia
D Hasin AA08159-07 653,170 Alcohol Dependence: General Population Validity
D Hasin DA10919-04 337,307 PRISM: Comorbidity Diagnosis for Drug Abuse Treatment Studies
A Hegde MH60225-01A1 262,270 Regulated Proteolysis and Long-Term Memory
R Hen Univ Of Penn 142,505 Subcontract w/Univ of Penn: Biology of Serotonin in the Brain: Project 6
R Hen Mount Sinai 86,368 Subcontract w/Mount Sinai: Hallucinogens and 5-HT2A Receptors
M Hofer MH40430-18 274,105 The Developmental Effects of Early Maternal Separation
C Hoven Cambridge Health 14,194 Consortium w/Cambridge Health Alliance: Children's Health Initiative II
C Hoven Columbia Univ 9,740 Subcontract w/Columbia Univ.: Trauma: Focused Intervention Targeting Risk
C Hoven Westchester Comm. 183,460 Subcontract w/Dept. of Community Mental Health: The Westchester Community
J Javitch Mt Sinai 97,763 Subcontract w/Mt. Sinai: Structure and Function of Neurotransmitter Transporters
H Kleber DA09236-07 1,906,863 Novel Medication Approaches for Substance Abuse
H Kleber DA12644-02 746,315 A Study of Anesthesia-Assisted Heroin Detoxification
H Kleber VACSP 542,796 A Phase 3 Placebo-Controlled, Double-Blind, Multi-Site Trial of Lofexidine
D Klein NARSAD 100,000 Investigation of Endogenous CO2 Sensitivity Using the Sleep Apneic Threshold
D Klein Pfizer 62,500 Sleep Apneic Threshold in Panic Disorder and Normals
J Kline AG15386-03 425,396 Epidemiology of Trisomy and Ovarian Age
J Knowles DA12190-01A2 401,559 Genetic Risk Factors for Nicotine Addiction
J Koester IBN-9808411 84,492 Behavioral Role and Neural Control of an Endogenously Bursting Neuron
L Kotler NARSAD 30,000 Understanding the Co-occurrence of Mood and Eating Disorders in Adolescent
I Kupfermann MH35564-27 273,502 Behavioral and Neural Analysis of Learning in Aplysia
M Laruelle MH54192-06 303,592 SPECT Imaging of Dopamine Function in Schizophrenia
F Levin DA11755-03 328,500 Methylphenidate Treatment for Cocaine Abuse and ADHD
F Levin Eli Lilly 47,536 Olanzapine Treatment of Marijuana and Cocaine Abuse among Schizophrenic Su
F Levin DA11444-04 549,103 Treatment of Adult ADHD in Methadone Patients
F Levin NARSAD 49,992 Treatment of Cocaine and/or Marijuana Abuse Among Patients with Schizophrenia
M Liebowitz Smithkline Beech 44,000 A Double-Blind, Placebo Controlled Study of the Efficacy and Tolerablilty
M Liebowitz MH55165-05 211,476 Long-Term Treatment of Social Phobia
M Liebowitz MH45436-08A1 333,805 CBT Augmentation of SRI Pharmacotherapy for OCD
M Liebowitz Warner Lambert 0 An 8-Week Double Blind Randomized Multicenter Flexible Dose Placebo Control
M Liebowitz MH40121-16 260,414 Pharmacotherapy of Social Phobia
S Lisanby MH60884-02 289,896 Magnetic Stimulation Therapy: A New Convulsive Treatment
C Lucas MH58371-03 223,795 Improving the Reliability of the DISC?
H M-Bahlburg HD38409-02 453,656 Psychobiology of Cogential Adrenal Hyperplasia (CAH)
D Malaspina MH59114-02 786,564 Jerusalem Perinatal Cohort Schizophrenia Study
J Mann MH56390-04 570,332 Familial Pathways to Early-onset Suicide Attempts
J Mann MH62185-01 2,126,024 Conte Centers for the Neuroscience of Mental Disorders (CCNMD): The Neurob
J Mann MH40210-16 355,694 Postmortem Neurochemical Studies in Suicide
J Martin NS36835-04A1 300,296 Activity Refines Corticospinal Terminations
D McDowell DA13191-01 386,394 Marijuana Pharmacotherapies: Controlled Clinical Trials
P McGrath MH56058-04 400,518 Prediction of Outcome During Fluoxetine Continuation
P McGrath Glaxo Wellcome 18,750 Open Study of Bupropion SR in the Treatment of Major Depressive Disorder Patients Who Fail to Respond or to Maintain Response to Fluoxetine Treatment
P McGrath Quintiles 722 Safety and Efficacy of Naltrel in Treatment of Alcohol Dependence
C Mellins W T Grant Fdnd 140,213 Youth Affected by HIV: Early Adolescent Predictors of Sexual and Drug Use
L Miller WT Grant 50,000 Religiosity and Resilience in Adolescents
L Mufson NARSAD 50,000 Group IPT for Depressed Adolescents
M Myers Columbia Univ 15,324 Subcontract w/ CU: Morphine Kinetics and Dynamics in Maternal and Fetal Baboons
M Myers Columbia Univ 67,467 Subcontract w/CU: Fetal Activity and Hypoxia During Development
M Myers Columbia Univ PA* 19,304 Subcontract w/CU: Hostility Reduction and Autonmic Control of the Heart
R Neugebauer MH59179-01A2 69,042 Preventing Depression After Miscarriage: A Pilot Study
E Nunes Alchol Bev Fdnd 40,000 Treatment of Alcohol Dependence with Comorbid Pathological Gambling
E Nunes DA10746-04 498,852 Opiate Dependence: Combined Naltrexone/Behavior Therapy
E Nunes DA13118-02 221,809 Behavioral Therapy for Depression in Drug Dependence
E Nunes DA13035-01A1 2,200,000 CU Partners: NY/Long Island Regional Node
L O'Sullivan Ford Foundation 395,000 HIV Center for Clinical & Behavioral Studies Gender Sexuality and Health:
M Oquendo MH59710-01A2 432,523 Pharmacotherapy of High-Risk Bipolar Disorder
L Papp NARSAD 49,954 Treatment Strategies for Comorbid Depression and Anxiety in Late-Life
G Pelton Jewish Communal 15,000 Effects of Peripheral Immune Stimulation on Brain Activity
E Petkova MH61968-01 78,232 Adolescent Eating Disorders: A Second Look
D Pine MH59171-02 505,275 Ventilatory Physiology in Children at Risk for Anxiety
D Pine MH57503-04 105,216 Fluoxetine's Effect on Anxiety and Breathing in Children
J Prudic MH59069-03 542,184 ECT Practices in Community Settings: Evaluating Outcomes
N Qian IBN-9817979 79,184 Computational and Psychophysical Studies of Visual Perceptual Learning
N Qian MH54125-06 204,294 Computation and Psychophysics of Motion and Stereopsis
J Rabkin MH52037-08 258,740 Mood Effects of Testosterone VS Fluoxetine in HIV Illness
J Rabkin MH60563-01A1 385,108 DHEA Effects on Mood in Depressed HIV+ Patients
W Raby Bristol-Myers 0 Evaluation of the Anxiolytic Effect of Serzone in Patients Suffering from
R Remien MH61173-02 678,836 Serodiscordant Couples, Medical Adherence and HIV Risk
L Role NARSAD 99,948 Molecular Mechanisms Underlying the Formation and Maintenance of Synapses
S Roose MH55716-04 399,810 Antidepressant Treatment of Melancholia in Late Life
E Rubin DA12271-03 329,128 PET Imaging: Comorbid Cocaine Dependence and Depression
H Sackeim MH35636-19 393,994 Affective and Cognitive Consequences of ECT
H Sackeim MH61609-01A1 214,143 Optimization of Electroconvulsive Therapy
S Salzinger MH48917-08 318,612 Adolescent Outcome of Physically Abused Schoolchildren
S Salzinger MH56198-04 889,028 Processes Linking Violence Exposure and Teenage Outcome
L Santarelli NARSAD 30,000 A Role for Neurogenesis in the Mechanism of Action of Antidepressants: A P
S Schacher IBN-9808938 98,137 Synapse Formation and Plasticity: Synapse Elimination
S Schacher MH60387-01A2 222,229 Mechanisms Mediating Long-Term Synaptic Plasticity
D Schechter AACAP 9,000 Maternal Attributions, Mental States and Interactive Behavior with Very Yo
D Schechter IPA 7,000 Maternal Attributions, Dissociative Mental States, Reflective Functioning,
C Schmauss NARSAD 50,000 Stimulation-dependent Activity of Dopamine D1 Receptors during Chronic Ina
F Schneier MH59850-02 327,402 Imaging of the Dopamine System in Social Phobia
J Schwartz Columbia Univ 158,197 Subcontract w/CU: Protein Kinase C Controls Synaptic Action and Behavior
D Shaffer MH60570-02 1,257,875 Child Psychiatry Intervention Research Center
A Skodol MH50839-05 222,436 Collaborative Longitudinal Study of Personality Disorders
B Stanley MH61017-01A1 812,276 Treating Suicidal Behavior and Self-Mutilation in BPD
B Stanley AFSP 48,815 Suicide Attempts and Factors Associated with High Lethality in Borderline
J Stewart Eli Lilly 0 Fluoxetine vs Placebo: Long Term Treatment of MDD
E Struening NYC #01206 25,468 CSS-Case Management Study: A Plus West 168th Street
E Struening NYC #01206 494,548 CSS-Shelter and Survey 93 Worth Street
E Struening NYC #01206 217,585 CSS-Shelter and Survey-93 Worth Street
G Sullivan ADAA 39,000 The Neural Substrates of Pathologic Anxiety
E Susser MH58917-03 545,835 Sexual Risk Reduction Among Men with Mental Illness
M Terman MH42931-12 318,127 Light and Ion Therapy for Seasonal Affective Disorder
W Tucker USDA 111,014 Psychiatric Telemedicine for Rural New York
H Verdeli NARSAD 30,000 A Preventive Intervention for Adolescent Children of Mothers with Bipolar
B Walsh MH60271-01A1 275,946 Fluoxetine After Weight Restoration in Anorexia Nervosa
T Walsh DK53635-04 235,050 Treatment of Bulimia Nervosa in a Primary Care Setting
R Waterhouse NS40402-01 257,106 Development of a PET Radiotracer for Sigma-1 Receptors
M Weissman MH60912-02 336,598 Genetics of Early-Onset Major Depression
A Whaley Columbia Univ. 89,440 Subcontract w/Columbia Univ.: Social Status and PTSD in Vietnam Veterans
A Whitaker MH57514-03 552,545 Epidemiology of Early CNS Injury & Psychopathology at 13
J Wilson Eli Lilly 9,000 A Pilot Study of the Effects of Fluoxetine on Negative Interactions between
Sponsored Research Totals 55,494,532
 
 [  HOME | RESEARCH & CLINICAL DIV. | CLINICAL DEPARTMENTS | EDUCATION IN PSYCHIATRY | SPECIAL ACTIVITIES & SPONSORED RESEARCH ]